Ganfeng Lithium stock
002460.SZSHZGanfeng Lithium Co., Ltd., Basic MaterialsISIN CNE100000SF6
51Score 51 out of 100, Neutral
Price and trend
41 / 100
Price history
−46% in one yearThe chart shows daily closes over 16 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 41% below it.
Since July 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 49).
The price is 60% below its 52-week high. Largest decline in 16 years: 84% (August 2021 to September 2024).
Chart figures for advanced users
- SMA 50$6.43
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$9.25
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)49
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$5.24
- The lowest closing price of the last twelve months.
- Resistance$13.71
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Ganfeng Lithium Co., Ltd. belongs to the Chemicals industry (China) and, with a market value of $11.5B, is number 14 of 44 companies in its industry on MEQIRI.
- For fiscal 2026, analysts expect on average revenue of $7.04B (up 103.4%) and adjusted earnings per share of $0.50 (up 335.7%).
- MEQIRI Score 51 out of 100 (Neutral): rank 299 of 461 in Basic Materials, median 57.
Show more
- The P/E is 11.6 (Chemicals median 19.2, own median of recent years 38.2).
- Our model puts fair value at $5.59, with the price 2% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Growing faster than its industryRevenue up 33.1% a year since 2020, Chemicals median 14.2%.Growth 88
- Modestly valuedP/E 11.6, Chemicals median 19.2, own median 38.2.Valuation 68
Weaknesses
- Interest barely coveredOperating profit covers interest only 0.5 times.Stability 42
- Margin fallingOperating margin 5.1%, average of the prior years 20.5% (to 2024).Profitability 61
- Share price fell sharplyDown 47% over the last 12 months.Momentum 15
Its standout strength is growth, while capital allocation and momentum hold the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 52 to 51.
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk not measured
How well MEQIRI warnsFor stocks from Japan, China, Hong Kong, Taiwan, Korea, Canada, India and Brazil we only show crash risk once a separate backtest shows that it warns as well there as in the US and Europe.
Valuation
Valuation signal
Fairly valuedIn our model the price counts as cheap below $3.99 and expensive above $9.32 (uncertainty high, based on the price swings of the past year).
The two parts of the fair value come to $2.07 (cash-flow model) and $9.11 (industry comparison), and the gap between them shows how uncertain the estimate is.
Calculated with a cost of equity of 7.3%. At 8.3% the fair value would be $5.42, at 6.3% it would be $5.85.
Valuation metrics
Half from the dividend model, half from earnings times the industry P/E (19.2).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 128% on the twelve months before. Revenue has grown strongly since 2007, at around 30% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 15%, operating 5%, net 7%. Last 12 months: net 15%.
Debt & balance sheet
latest quarterDebt is moderate, but interest coverage is weak. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 1 Apr 2027in 139 days
- Last reported
- 15 Oct 2026EPS reported $0.05 (expected $0.11)below expectations
Analyst estimates
Analysts have cut their 2027 earnings estimate by 3.1% since 28 Oct 2026. Falling estimates often precede bad news.
- Earnings per share
- $0.50+3.5%
- Revenue
- $7.04B−0.2%
- Earnings per share
- $0.46−3.1%
- Revenue
- $7.36B−1.6%
MEQIRI has stored the estimates since 28 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at Ganfeng Lithium
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
461 rated companies in Basic Materials
- This company
- 51
- Sector median
- 57
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals
The next larger and next smaller companies by market value
- Zangge Mining000408.SZ $15.19B71
- Zhejiang Juhua600160.SS $12.86B62
- LG Chem051910.KS $12.78B39
- Formosa Chemicals & Fibre1326.TW $12.68B52
- Jiangsu Eastern Shenghong000301.SZ $9.87B47
- Mitsubishi Chemical Group4188.T $9.2B55
- SasolSSL $9.19B59
- Syensqo SA/NVSYENS.BR $8.98B54
ETFs that hold Ganfeng Lithium
Held by 95 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| L&G Battery Value-Chain UCITS ETFBATE | 1.07% | 0.49% | €668.78M |
| Invesco Global Clean Energy UCITS ETF AccumUSDG1CE | 0.67% | 0.60% | €88.94M |
| WisdomTree Strategic Metals and Rare Earths Miners UCITS ETF USD AccRARE | 0.33% | 0.50% | €604M |
Show 5 more
| WisdomTree Battery Solutions UCITS ETF USD AccW1TA | 0.28% | 0.40% | €132.27M |
| Xtrackers Harvest CSI300 UCITS ETF 1DRQFI | 0.19% | 0.65% | €251.68M |
| Amundi MSCI New Energy UCITS ETF DistLYM9 | 0.18% | 0.60% | €976.93M |
| Xtrackers Harvest CSI A500 UCITS ETF 1DAH50 | 0.17% | 0.65% | €10.81M |
| Xtrackers MSCI China A UCITS ETF 1CDBX9 | 0.14% | 0.35% | €107.81M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = CN¥6.6683)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 4 Nov 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.